119 related articles for article (PubMed ID: 35388001)
1. STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming.
Chu Z; Gu L; Hu Y; Zhang X; Li M; Chen J; Teng D; Huang M; Shen CH; Cai L; Yoshida T; Qi Y; Niu Z; Feng A; Geng S; Frederick DT; Specht E; Piris A; Sullivan RJ; Flaherty KT; Boland GM; Georgopoulos K; Liu D; Shi Y; Zheng B
Nat Commun; 2022 Apr; 13(1):1859. PubMed ID: 35388001
[TBL] [Abstract][Full Text] [Related]
2. Distinct and overlapping roles of STAG1 and STAG2 in cohesin localization and gene expression in embryonic stem cells.
Arruda NL; Carico ZM; Justice M; Liu YF; Zhou J; Stefan HC; Dowen JM
Epigenetics Chromatin; 2020 Aug; 13(1):32. PubMed ID: 32778134
[TBL] [Abstract][Full Text] [Related]
3. STAG2 mutations regulate 3D genome organization, chromatin loops, and Polycomb signaling in glioblastoma multiforme.
Xu W; Kim JS; Yang T; Ya A; Sadzewicz L; Tallon L; Harris BT; Sarkaria J; Jin F; Waldman T
J Biol Chem; 2024 May; 300(6):107341. PubMed ID: 38705393
[TBL] [Abstract][Full Text] [Related]
4. Synthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1.
Benedetti L; Cereda M; Monteverde L; Desai N; Ciccarelli FD
Oncotarget; 2017 Jun; 8(23):37619-37632. PubMed ID: 28430577
[TBL] [Abstract][Full Text] [Related]
5. Second reported individual with a partial STAG2 deletion: middle interhemispheric variant holoprosencephaly in STAG2-related cohesinopathy.
Cratsenberg DM; Winningham PJ; Starr LJ
Clin Dysmorphol; 2021 Jul; 30(3):159-163. PubMed ID: 33758131
[No Abstract] [Full Text] [Related]
6. Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very young.
Kimura S; Polonen P; Montefiori L; Park CS; Iacobucci I; Yeoh AE; Attarbaschi A; Moore AS; Brown A; Manabe A; Buldini B; Freeman BB; Chen C; Cheng C; Kean Hui C; Li CK; Pui CH; Qu C; Tomizawa D; Teachey DT; Varotto E; Paietta EM; Arnold ED; Locatelli F; Escherich G; Elisa Muhle H; Marquart HV; de Groot-Kruseman HA; Rowe JM; Stary J; Trka J; Choi JK; Meijerink JPP; Yang JJ; Takita J; Pawinska-Wasikowska K; Roberts KG; Han K; Caldwell KJ; Schmiegelow K; Crews KR; Eguchi M; Schrappe M; Zimmerman M; Takagi M; Maybury M; Svaton M; Reiterova M; Kicinski M; Prater MS; Kato M; Reyes N; Spinelli O; Thomas P; Mazilier P; Gao Q; Masetti R; Kotecha RS; Pieters R; Elitzur S; Luger SM; Mitchell S; Pruett-Miller SM; Shen S; Jeha S; Köhrer S; Kornblau SM; Skoczeń S; Miyamura T; Vincent TL; Imamura T; Conter V; Tang Y; Liu YC; Chang Y; Gu Z; Cheng Z; Yinmei Z; Inaba H; Mullighan CG
medRxiv; 2023 Nov; ():. PubMed ID: 37986997
[TBL] [Abstract][Full Text] [Related]
7. Biologic and clinical analysis of childhood gamma delta T-ALL identifies LMO2/STAG2 rearrangements as extremely high-risk.
Kimura S; Park CS; Montefiori LE; Iacobucci I; Polonen P; Gao Q; Arnold ED; Attarbaschi A; Brown A; Buldini B; Caldwell KJ; Chang Y; Chen C; Cheng C; Cheng Z; Choi J; Conter V; Crews KR; de Groot-Kruseman HA; Deguchi T; Eguchi M; Muhle HE; Elitzur S; Escherich G; Freeman BB; Gu Z; Han K; Horibe K; Imamura T; Jeha S; Kato M; Chiew KH; Khan T; Kicinski M; Kohrer S; Kornblau SM; Kotecha RS; Li CK; Liu YC; Locatelli F; Luger SM; Paietta EM; Manabe A; Marquart HV; Masetti R; Maybury M; Mazilier P; Meijerink JPP; Mitchell S; Miyamura T; Moore AS; Oshima K; Pawinska-Wasikowska K; Pieters R; Prater MS; Pruett-Miller SM; Pui CH; Qu C; Reiterova M; Reyes N; Roberts KG; Rowe JM; Sato A; Schmiegelow K; Schrappe M; Shen S; Skoczen S; Spinelli O; Stary J; Svaton M; Takagi M; Takita J; Tang Y; Teachey DT; Thomas PG; Tomizawa D; Trka J; Varotto E; Vincent TL; Yang JJ; Yeoh AE; Zhou Y; Zimmermann M; Inaba H; Mullighan CG
Cancer Discov; 2024 Jun; ():. PubMed ID: 38916500
[TBL] [Abstract][Full Text] [Related]
8. Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis.
Ozmadenci D; Shankara Narayanan JS; Andrew J; Ojalill M; Barrie AM; Jiang S; Iyer S; Chen XL; Rose M; Estrada V; Molinolo A; Bertotto T; Mikulski Z; McHale MC; White RR; Connolly DC; Pachter JA; Kuchroo VK; Stupack DG; Schlaepfer DD
Proc Natl Acad Sci U S A; 2022 Apr; 119(17):e2117065119. PubMed ID: 35467979
[TBL] [Abstract][Full Text] [Related]
9. LAG3 associates with TCR-CD3 complexes and suppresses signaling by driving co-receptor-Lck dissociation.
Guy C; Mitrea DM; Chou PC; Temirov J; Vignali KM; Liu X; Zhang H; Kriwacki R; Bruchez MP; Watkins SC; Workman CJ; Vignali DAA
Nat Immunol; 2022 May; 23(5):757-767. PubMed ID: 35437325
[TBL] [Abstract][Full Text] [Related]
10. Robust delivery of RIG-I agonists using extracellular vesicles for anti-cancer immunotherapy.
Peng B; Nguyen TM; Jayasinghe MK; Gao C; Pham TT; Vu LT; Yeo EYM; Yap G; Wang L; Goh BC; Tam WL; Luo D; Le MT
J Extracell Vesicles; 2022 Apr; 11(4):e12187. PubMed ID: 35430766
[TBL] [Abstract][Full Text] [Related]
11. Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma.
Alonso-Nocelo M; Ruiz-Cañas L; Sancho P; Görgülü K; Alcalá S; Pedrero C; Vallespinos M; López-Gil JC; Ochando M; García-García E; David Trabulo SM; Martinelli P; Sánchez-Tomero P; Sánchez-Palomo C; Gonzalez-Santamaría P; Yuste L; Wörmann SM; Kabacaoğlu D; Earl J; Martin A; Salvador F; Valle S; Martin-Hijano L; Carrato A; Erkan M; García-Bermejo L; Hermann PC; Algül H; Moreno-Bueno G; Heeschen C; Portillo F; Cano A; Sainz B
Gut; 2023 Feb; 72(2):345-359. PubMed ID: 35428659
[TBL] [Abstract][Full Text] [Related]
12. Modular design of synthetic receptors for programmed gene regulation in cell therapies.
Zhu I; Liu R; Garcia JM; Hyrenius-Wittsten A; Piraner DI; Alavi J; Israni DV; Liu B; Khalil AS; Roybal KT
Cell; 2022 Apr; 185(8):1431-1443.e16. PubMed ID: 35427499
[TBL] [Abstract][Full Text] [Related]
13. CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity.
Bernareggi D; Xie Q; Prager BC; Yun J; Cruz LS; Pham TV; Kim W; Lee X; Coffey M; Zalfa C; Azmoon P; Zhu H; Tamayo P; Rich JN; Kaufman DS
Nat Commun; 2022 Apr; 13(1):1899. PubMed ID: 35393416
[TBL] [Abstract][Full Text] [Related]
14. Tuning T cell receptor sensitivity through catch bond engineering.
Zhao X; Kolawole EM; Chan W; Feng Y; Yang X; Gee MH; Jude KM; Sibener LV; Fordyce PM; Germain RN; Evavold BD; Garcia KC
Science; 2022 Apr; 376(6589):eabl5282. PubMed ID: 35389803
[TBL] [Abstract][Full Text] [Related]
15. Programme of self-reactive innate-like T cell-mediated cancer immunity.
Chou C; Zhang X; Krishna C; Nixon BG; Dadi S; Capistrano KJ; Kansler ER; Steele M; Han J; Shyu A; Zhang J; Stamatiades EG; Liu M; Li S; Do MH; Edwards C; Kang DS; Chen CT; Wei IH; Pappou EP; Weiser MR; Garcia-Aguilar J; Smith JJ; Leslie CS; Li MO
Nature; 2022 May; 605(7908):139-145. PubMed ID: 35444279
[TBL] [Abstract][Full Text] [Related]
16. When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer.
Hasim MS; Marotel M; Hodgins JJ; Vulpis E; Makinson OJ; Asif S; Shih HY; Scheer AK; MacMillan O; Alonso FG; Burke KP; Cook DP; Li R; Petrucci MT; Santoni A; Fallon PG; Sharpe AH; Sciumè G; Veillette A; Zingoni A; Gray DA; McCurdy A; Ardolino M
Sci Adv; 2022 Apr; 8(15):eabj3286. PubMed ID: 35417234
[TBL] [Abstract][Full Text] [Related]
17. Plasma Olink Proteomics Identifies CCL20 as a Novel Predictive and Diagnostic Inflammatory Marker for Preeclampsia.
Wang X; Yip KC; He A; Tang J; Liu S; Yan R; Zhang Q; Li R
J Proteome Res; 2022 Dec; 21(12):2998-3006. PubMed ID: 36301636
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Regulation of MAP3K8 in EBV-Associated Gastric Carcinoma.
Roy G; Yang T; Liu S; Luo YL; Liu Y; Zhong Q
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768307
[TBL] [Abstract][Full Text] [Related]
19. Somatic mosaicism in
Schmidt J; Dreha-Kulaczewski S; Zafeiriou MP; Schreiber MK; Wilken B; Funke R; Neuhofer CM; Altmüller J; Thiele H; Nürnberg P; Biskup S; Li Y; Zimmermann WH; Kaulfuß S; Yigit G; Wollnik B
Front Cell Dev Biol; 2022; 10():1025332. PubMed ID: 36467423
[TBL] [Abstract][Full Text] [Related]
20. Role of 5-methylcytosine in determining the prognosis, tumor microenvironment, and applicability of precision medicine in patients with hepatocellular carcinoma.
Luan M; Zhao M; Wang H; Xu R; Cai J
Front Genet; 2022; 13():984033. PubMed ID: 36186468
[No Abstract] [Full Text] [Related]
[Next] [New Search]
